All compounds

A small-molecule NNMT inhibitor, not a peptide, with metabolic findings chiefly from cells and mice.

An experimental research chemical discussed online, with no established human safety or clinical evidence.

AHK-Cu 50mg is a copper tripeptide supplied in a branded pre-filled pen with case, available only following online consultation and clinician approval.

A choline-containing supplement involved in acetylcholine biology; evidence for cognitive effects is mixed.

AOD-9604 5mg is supplied in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.

A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.

A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.

A compound studied primarily in Russia, with limited independent evidence and uncertain status.

Cardiogen 20mg is a short peptide bioregulator associated with cardiac tissue research, available only following online consultation and clinician approval.

A dual-secretagogue blend with uncertain formulation and no robust clinical evidence for the marketed combination.

A label commonly used for modified GRF(1–29), distinct from the albumin-binding CJC-1295 studied in published trials.

An albumin-binding GHRH analogue studied in small human trials for hormonal responses, not proven wellness outcomes.

Cortagen 20mg is a short peptide bioregulator associated with brain tissue research, available only following online consultation and clinician approval.

A peptide discussed in sleep research, but not supported by strong evidence for routine use.

An investigational peptide that some people ask about in relation to ageing biology and sleep rhythms.

A copper-binding tripeptide used in cosmetic formulations, with limited human skin evidence and route-specific uncertainties.

GHRP-2 5mg in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

GLOW Blend combines BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

A glutathione product for discussion with a clinician, with evidence and suitability varying by route.

A synthetic version of natural GnRH used in specific endocrine settings, not an established general libido or testosterone option.

Hexarelin 2mg is a synthetic growth hormone secretagogue, supplied in a branded pre-filled pen with case only following online consultation and clinician approval.

HGH Fragment 176-191 5mg is available in a branded pre-filled pen with case, subject to online consultation and clinician approval.

Humanin 10mg is a mitochondrial-derived peptide, supplied in a branded pre-filled pen with case, subject to online consultation and clinician approval.

A synthetic ghrelin-receptor agonist with early human pharmacology data, not established body-composition or sleep outcomes.

A short KISS1-derived peptide involved in reproductive hormone signalling, with exploratory human studies rather than established intimacy benefits.

KLOW Blend 80mg combines KPV, BPC-157, TB-500 and GHK-Cu in a branded pre-filled pen, available only following online consultation and clinician approval.

A three-amino-acid fragment of alpha-MSH explored mainly in laboratory and animal models of inflammatory signalling.

A naturally occurring nutrient involved in mitochondrial fatty-acid transport, with benefits dependent on the clinical setting.

An amino acid found in tea, studied for relaxation and attention with modest, mixed evidence.

Lipo-C with B12 10ml combines five ingredients in a branded pre-filled pen, available only following online consultation and clinician approval.

A human cathelicidin peptide with complex immune effects; topical wound studies do not establish injectable benefit.

A medicinal dye with established medical uses in specific settings, but not proven as a general cognitive enhancer.

A mitochondrial-derived peptide of interest in early metabolic research, with substantial uncertainty about human use.

A clinician-led option for people asking about NAD+, with suitability assessed in an online consultation.

A clinician-led option for people asking about NAD+, with suitability assessed in an online consultation.

A synthetic compound discussed for cognition, with limited evidence and uncertain regulatory status.

A racetam compound studied for cognition, with insufficient evidence for general use.

A naturally occurring hormone with complex effects; any prescribed use requires careful individual assessment.

PE-22-28 10mg is a spadin analogue with predominantly preclinical evidence, available through Welcuren only following online consultation, clinician approval and confirmation of lawful supply.

Pinealon 10mg is a tripeptide bioregulator supplied in a branded pre-filled pen with case, subject to online consultation and clinician approval.

A racetam medicine used in some jurisdictions for specific indications, not an established general focus supplement.

A dietary supplement discussed for mitochondrial biology, while human evidence remains preliminary.

An experimental cognitive compound supported by very little human research.

A melanocortin receptor agonist with a narrow US licensed indication for acquired, generalised HSDD in premenopausal women.

An investigational triple-hormone peptide, considered only after a full clinician consultation.

A synthetic peptide with limited human evidence and no established role in routine care.

A peptide studied in some countries for neurological questions; evidence does not establish general cognitive benefit.

A synthetic GHRH(1–29) analogue with historical US paediatric and diagnostic authorisations, not an established anti-ageing option.

A mitochondria-targeting peptide studied in clinical settings, with potential use dependent on product and clinician assessment.

A thymosin beta-4-associated product whose identity and human evidence must not be assumed from its marketing name.

A GHRH analogue with a specific US indication for excess abdominal fat in adults with HIV-associated lipodystrophy.

Thymalin 10mg is a thymus-derived peptide preparation, supplied in a branded pre-filled pen with case only after online consultation and clinician approval.

A synthetic version of a thymic peptide with country-specific approvals and mixed clinical evidence across settings.

VIP 5mg is a naturally occurring neuropeptide, offered in a branded pre-filled pen with case only following online consultation and clinician approval.